Joshua Baisley – Nutrasource Pharmaceutical & Nutraceutical Services
Vice President Clinical Design & Delivery Joshua Baisley, B.Sc. Honors, Vice President Clinical Design & Delivery, joined Nutrasource in 2013, bringing 12 years of clinical, pre-clinical and regulatory natural health product experience. He also has four years’ experience in early stage … [Read more...] about Joshua Baisley – Nutrasource Pharmaceutical & Nutraceutical Services
HPA (China) News – December 2022
HPA (China) News – May 2022
Nuvozymes released the“Pylopass™ and Helicobacter pylori White Paper” Morinaga Milk's strain Bifidobacterium longum subsp. BB536 was approved for use in China infant food Morinaga Milk's strain Bifidobacterium infantis M-63 has obtained FDA's GRAS (Generally Recognized as Safe). Vland … [Read more...] about HPA (China) News – May 2022
How to Interpret the Results of a Probiotic Clinical Trial
written by Susan Hewlings, PhD, RD, Director, Scientific Affairs at Nutrasource - IPA Education & Communication member Evidence-based medicine (EBM) is a term that has gained a lot of traction in most health-related disciplines. It seems like a good idea to make health-related decisions based … [Read more...] about How to Interpret the Results of a Probiotic Clinical Trial
HPA (China) News – April 2022
Probiotics China team interviewed Sacco CSL with its CEO for Asia-Pacific, Mr. John Goebel. Two Probiotics related products from AB-Biotics, the Lipigo and AB-21 won the 2022 Nutraingredients Awards. AB-Biotics presented its starter product Yogumel for making yogurt or kefir at the Alimentaria … [Read more...] about HPA (China) News – April 2022